The digital health world is constantly changing, and investors never know which startup will be next to hit unicorn status.
Here are three emerging digital health companies' funding rounds:
- Nectar, a digital allergy treatment platform, raised $16.5 million in its series A financing round.
- Carallel, a company that provides digital tools to family caregivers, raised $8.2 million in a series A financing round led by FCA Venture Partners.
- Parallel Bio, a biotech company working to replicate the human immune system in a dish, raised $4.3 million in its seed financing round.